Mladsi D, Zhou X, Mader G, Sanon M, Wang J, Barnett C, Willey C, Seliger S. Mortality risk in patients with autosomal dominant polycystic kidney disease. BMC Nephrol. 2024 Feb 16;25(1):56. doi: 10.1186/s12882-024-03484-3
Danese D, Goss D, Romano (DeMuro) C, Gupta C. Qualitative assessment of the patient experience of primary hyperoxaluria type 1: an observational study. BMC Nephrol. 2023 Oct 26;24(1):319. doi: 10.1186/s12882-023-03365-1
Mader G, Mladsi D, Sanon M, Purser M, Barnett CL, Oberdhan D, Watnick T, Seliger S. A disease progression model estimating the benefit of tolvaptan on time to end-stage renal disease for patients with rapidly progressing autosomal dominant polycystic kidney disease. BMC Nephrol. 2022 Oct 18;23(1):334. doi: 10.1186/s12882-022-02956-8
Barnes TL, Ahuja M, MacLeod S, Tkatch R, Albright L, Schaeffer JA, Yeh CS. Loneliness, social isolation, and all-cause mortality in a large sample of older adults. J Aging Health. 2022 Oct;34(6-8):883-92. doi: 10.1177/08982643221074857
Finlay J, Esposito M, Li M, Kobayashi LC, Khan AM, Gomez-Lopez I, Melendez R, Colabianchi N, Judd S, Clarke PJ. Can neighborhood social infrastructure modify cognitive function? a mixed-methods study of urban-dwelling aging Americans. J Aging Health. 2021 Oct;33(9):772-85. doi: 10.1177/08982643211008673